A mixture of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Remarks:

Type of genotoxicity: gene mutation

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1990

Report date:

1990

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

GLP compliance:

yes

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

A mixture of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane

EC Number:

406-750-9

EC Name:

A mixture of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane

Cas Number:

129757-67-1

Molecular formula:

C44 H84 N2 O6 + C80 H150 N4 O12 737.16 g/mol + 1360.1 g/mol

IUPAC Name:

2,2,6,6-tetramethyl-1-(octyloxy)piperidin-4-yl 2,2,6,6-tetramethyl-1-{[8-({2,2,6,6-tetramethyl-4-[(10-oxo-10-{[2,2,6,6-tetramethyl-1-(octyloxy)piperidin-4-yl]oxy}decanoyl)oxy]piperidin-1-yl}oxy)octyl]oxy}piperidin-4-yl decanedioate; 2,2,6,6-tetramethyl-1-(octyloxy)piperidin-4-yl 2,2,6,6-tetramethyl-4-{[8-({2,2,6,6-tetramethyl-1-[(10-oxo-10-{[2,2,6,6-tetramethyl-1-(octyloxy)piperidin-4-yl]oxy}decanoyl)oxy]piperidin-4-yl}oxy)octyl]oxy}piperidin-1-yl decanedioate; bis[2,2,6,6-tetramethyl-1-(octyloxy)piperidin-4-yl] decanedioate

Details on test material:

- State of aggregation: liquid

Method

Species / strain

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2

Metabolic activation:

with and without

Metabolic activation system:

Aroclor-induced rat-liver S9 mix

Test concentrations with justification for top dose:

preliminary toxicity test without metabolic activation: 20 - 5000 µg/plate
main test (with and without metabolic activation): 313, 625, 1250, 2500 and 5000 µg/plate

Vehicle / solvent:

Acetone

Controls

Untreated negative controls:

yes

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

other: see "Details on test system"

Details on test system and experimental conditions:

NUMBER OF REPLICATIONS: 3METHOD OF APPLICATION: in agar (plate incorporation)

DURATION
- Exposure duration: 48h

NUMBER OF REPLICATIONS: three Petri dishes are prepared per strain and per group

DETERMINATION OF CYTOTOXICITY
- Method: ; relative total growth

- POSITIVE CONTROLS
WITHOUT S9
1) for strain TA 98: 2-nitrofluorene, 10 µg/plate in dimethylsulfoxide
2) for strains TA 100 and TA 1535: sodium azide, 2.0 µg/plate in bidistilled water
3) for strain TA 1537: 9 (5)-aminoacridine hydrochloride monohydrate, 150 µg/plate in dimethylsulfoxide
4) for strain E. coli: 4-nitroquinoline-N-oxide, 1 µg/plate in dimethylsulfoxide.

WITH S9
1) for strains TA 98 and TA 100: 2-aminoanthracene, 2.5 µg/plate in dimethylsulfoxide
2) for strain TA 1535: cyclophosphamide monohydrate, 400 µg/plate in bidistilled water
3) for strain TA 1537: 2-aminoanthracene, 5µg/plate in dimethylsulfoxide;
4) for strain E. coli WP2uvrA: 2-aminoanthracene, 50 µg/plate in dimethylsulfoxide
.

Evaluation criteria:

Criteria for a positive response:
The test substance is considered to be positive in this test system if one or both of the following conditions are met:
- at least a reproducible doubling of the mean number of revertants per plate above that of the negative control at any concentration level for one or more of the following strains: TA 98, TA 1535, TA 1537 and E. coli
- a reproducible increase of the mean number of revertants per plate for any concentration above that of the negative control by at least a factor of 1.5 for strain TA 100.
Generally a concentration-related effect should be demonstrable.
Assay acceptance criteria:
A test is considered acceptable if the mean colony counts of the control values of all strains are within the acceptable ranges and if the results of the positive controls meet the criteria for a positive response.
In either case the final decision has to be based on scientific judgement.

Results and discussion

Test results

Key result

Species / strain:

other: S.typhimurium TA 98, TA 100, TA 1535, TA 1537; Escherichia coli WP2uvrA

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

no cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

not applicable

Positive controls validity:

valid

Additional information on results:

RANGE-FINDING/SCREENING STUDIES:
Nine concentrations of the test item ranging from 20 to 5000 µg/0.1 ml were tested to determine the highest concentration to be used in the mutagenicity assay. From the results obtained, the highest concentration suitable for the mutagenicity test was found to be 5000 µg/0.1 ml.

Any other information on results incl. tables

EXPERIMENTAL RESULT

Experiment 1

	TA 1535		TA 100		TA 1537		TA 98		WP2uvrA
Dose (µg/plate)	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9
0	20	13	116	130	12	11	29	35	26	33
313	13	16	108	121	8	13	23	52	22	31
625	13	17	114	124	9	12	18	43	13	33
1250	13	13	99	123	9	15	21	39	16	26
2500	17	15	114	115	10	13	18	43	26	37
5000	13	9	98	142	9	11	26	50	17	36
positive control	568	451	606	1781	1225	307	1225	815	443	1223

Experiment 2

	TA 1535		TA 100		TA 1537		TA 98		WP2uvrA
Dose (µg/plate)	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9
0	8	12	138	120	8	11	23	34	16	23
312.5	9	11	132	147	8	13	18	40	23	27
625	12	6	162	148	10	12	24	36	17	24
1250	9	12	133	129	9	13	16	34	27	17
2500	11	8	148	128	10	11	20	46	16	27
5000	11	10	140	134	7	11	20	48	26	19
positive control	455	477	667	1481	1585	126	1520	1184	379	546

Applicant's summary and conclusion

Conclusions:

In the experiments performed without and with microsomal activation none of the tested concentrations of the test item led to an increase in the incidence of both histidine- or tryptophan-prototrophic mutants by comparison with the negative control.